TAZ anticorps (C-Term)

N° du produit ABIN185489

Détail du produit anti-TAZ anticorps

Antigène: TAZ (Tafazzin (TAZ))

Épitope: C-Term

Reactivité: Humain

Hôte: Chèvre

Clonalité: Polyclonal

Conjugué: Cet anticorp TAZ est non-conjugé

Application: Western Blotting (WB), ELISA

Fonction: Tafazzin

Séquence: HLKTQAEQLH NH

Specificité: This antibody is expected to recognise isoforms 1to 4 (NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1, respectively).

Réactivité croisée: Chien, Humain, Souris, Rat

Purification: Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.

Classe de qualité: Verified

Immunogène: Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1.

Isotype: IgG

Information d'application

Indications d'application:

Western Blot: Approx 28 kDa band observed in Human Heart lysates (calculated MW of 33.5 kDa according to NP_000107.1, 30.2 kDa according to NP_851828.1, 31.7 kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0

Peptide ELISA: antibody detection limit dilution 1:32000.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 0.5 mg/mL

Buffer: Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.

Agent conservateur: Sodium azide

Précaution d'utilisation: This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Conseil sur la manipulation: Minimize freezing and thawing.

Stock: -20 °C

Stockage commentaire: Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.

Détails sur TAZ

Antigène: TAZ (Tafazzin (TAZ))

Autre désignation: TAZ (TAZ Produits)

Synonymes: anticorps wu:fb39f12, anticorps zgc:91803, anticorps MGC54019, anticorps TAZ, anticorps taz, anticorps GB11956, anticorps Afu2g13960, anticorps BTHS, anticorps CMD3A, anticorps EFE, anticorps EFE2, anticorps G4.5, anticorps LVNCX, anticorps Taz1, anticorps 5031411C02Rik, anticorps 9130012G04Rik, anticorps AW107266, anticorps AW552613, anticorps tafazzin, anticorps tafazzin L homeolog, anticorps tafazzin homolog, anticorps TAZ, anticorps taz, anticorps taz.L, anticorps LOC550948, anticorps AFUA_2G13960, anticorps AOR_1_318014, anticorps Tsp_06712, anticorps Taz

Sujet: TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2 , OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked), tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNC

ID gène: 6901

NCBI Accession: NP_000107, NP_851828, NP_851829, NP_851830